Skip to content
Home/Companies/Healthcare/CODENOS BIOFUTUR

CODENOS BIOFUTUR

Healthcare·France·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns CODENOS BIOFUTUR?

CODENOS BIOFUTUR was owned by Omnes Capital through Omnes Croissance 4 (2017 vintage) from 2019 to 2023, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Omnes Capital
Investor
Omnes Capital
Omnes Croissance 4 · 2017

Key facts

HQFrance
SectorHealthcare
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2023

More from Omnes Croissance 4

Other portfolio companies in the same fund.

Omnipart
Active
Business ServicesFrance· 2019
Prediwatt
Active
Business ServicesFrance· 2019
NH Theraguix
Active
Business ServicesFrance· 2018
Bimedia Finance
Exited 2018
SoftwareFrance· 2017
to
CIRCET RESEAUX
Circet Reseaux
Exited 2017
SoftwareFrance· 2017
to
Greenbureau
Exited 2023
SoftwareFrance· 2017

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Codenos Biofutur

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Codenos Biofutur?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Codenos Biofutur.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue